← Back to blog
A woman in soft focus stands in a wheat field at sunset. In the background, a man sits on a porch with a golden retriever. Caption reads: Is anyone asking their doctor?

Ask Your Doctor

The commercials we grew up with had the right tagline. Most people had the wrong question.
Listen to this post
↓ Download audio

You remember the ads. You can probably hum the music.

A woman in soft focus walks through a wheat field. A man stares out a window with a sad-looking dog. A cartoon blob looks downcast under a rain cloud. Soft piano. Warm voiceover.

Are you feeling tired? Anxious? Having trouble sleeping? Ask your doctor about [insert antidepressant here].

Then the speed-read at the end. Thirty seconds of fine print delivered like an auctioneer:

May cause nausea, dizziness, weight gain, sexual dysfunction, insomnia, sleep disturbance, brain zaps, emotional blunting, withdrawal symptoms upon discontinuation, increased risk of suicidal thoughts in young adults, serotonin syndrome, and in rare cases death. Tell your doctor if you experience...

Cut back to the woman in the field. Smiling now. Sun on her face. The dog wags its tail.

Ask your doctor. 🙂

· · ·

The campaign worked

The campaign worked: a line chart showing U.S. antidepressant use rising from 2.5% of adults in 1988 to 16.6% in 2024. Event markers: 1988 Prozac approved, 1993 Effexor approved, 1997 DTC drug ads loosened, 1998 folic acid mandate active, 1999 Columbine, 2004 FDA black-box warning added, 2020 COVID.

It worked so well that today, roughly one in seven American adults is on an antidepressant. About 17% of women. Nearly one in four women over sixty.

Most of them got there from a fifteen-minute consult. A symptom checklist. A prescription pad. No genetic panel. No diet question. No B12 test. No folate test. No conversation about sleep, movement, inflammation, thyroid, or anything else upstream.

CDC's own data: 68% of people on antidepressants have been on them for two years or more. One in four for ten years or more.

The campaign worked.

· · ·

How we got here

How we got here: a timeline from 1993 to 1998 marking three FDA events. December 1993, FDA approves new SNRI class. August 1997, DTC drug advertising rules loosened. January 1998, synthetic folic acid mandate active. Below the timeline, a chart showing antidepressant use rising sixfold over the following thirty years.

In a five-year window, three things changed at the same time.

December 1993 — the FDA approved a new class of antidepressant. SSRIs were already on the market. The new arrival was an SNRI — broader receptor reach, more aggressive marketing, easier to prescribe.

October 1993 to January 1998 — the FDA proposed, finalized, and rolled out a mandate to add synthetic folic acid to every enriched grain product sold in the United States. Bread. Pasta. Rice. Cereal. Cornmeal. Everything with the word "enriched" on the label. Mandatory.

August 1997 — the FDA loosened the rules on broadcast advertising for prescription drugs. Before that change, TV ads for prescription drugs had to disclose every side effect in full — which made them effectively impossible to produce. After 1997, manufacturers could refer viewers to a website and an 800 number for the full warnings. Ask your doctor was born.

The new drugs. The fortified food. The TV ads.

Three things. Same window.

Over the next thirty years, antidepressant use in the US increased six-fold.

Coincidence?

· · ·

What the speed-read didn't have time for

How the system runs: Made. Used. Cleared. A three-panel biological illustration showing how neurotransmitters are made from food-derived cofactors (folate, B12, B6, iron, magnesium, amino acids), released into the synapse, and cleared by reuptake transporters and the cleanup enzymes MAO-A and COMT.

Your brain makes serotonin, dopamine, and norepinephrine from raw materials in your food. Folate. B12. B6. Iron. Magnesium. Amino acids from protein. The cofactors the methylation cycle needs to build neurotransmitters in the first place.

The transmitter fires across the synapse. Does its job. Gets cleaned up by reuptake transporters and enzymes — MAO-A inside the cell, COMT in the prefrontal cortex.

Made. Used. Cleared. Repeat.

When you walk in tired, low, foggy, anxious — the question is which part of that chain is broken. Are you not making enough? Are you not clearing what you have? Is the supply line out? Is the cleanup crew slow? Is your thyroid off? Is your sleep wrecked? Is your gut absorbing what you eat?

The fifteen-minute consult doesn't ask any of those questions.

It hands you a drug that blocks the cleanup crew.

· · ·

The kitchen

The kitchen: a split image showing an empty restaurant pantry on the left, with a handwritten note pinned to the shelf that reads 'Nobody checked the ingredients.' On the right, a busy dining room where a manager gestures at two busboys, telling them to stop clearing the towering stacks of plates.

Picture a restaurant.

The customers are hungry. The plates aren't coming out. The dining room is restless.

Management walks in and looks at the situation. They don't check the pantry. They don't look at the ingredients. They don't ask the chef if there's anything to cook.

They turn to the busboys and say: stop clearing the plates.

For a moment, the room looks fuller. There are more plates on the table. The customers see motion. But the kitchen problem was never solved. The pantry was never checked.

That's the SSRI move. Block reuptake. Keep what little signal is there in the synapse a little longer. The plates pile up at the table while the kitchen sits empty.

An MAOI goes further — it doesn't just stop the busboys, it fires them. There's a place for MAOIs when nothing else has worked. But what doesn't make sense, in any class of antidepressant, is shutting down the cleanup crew before anyone asked whether the kitchen had ingredients to cook with.

Before we slow reuptake, before we inhibit cleanup, before we raise the dose — did anyone check the pantry?

· · ·

Compare it to aspirin

Two answers: a side-by-side comparison. The aspirin side shows a clean five-step cascade in red blood vessel anatomy: damaged artery wall, platelets stick, thromboxane A2 released, aspirin blocks COX-1 enzyme, clot prevented. The SNRI side shows neurotransmitters in the synapse, SNRI blocks reuptake, more signal for longer, then a fog labeled 'neuroplasticity (4 to 6 weeks?)', then symptoms may improve. A purple 'BELIEVED' stamp is in the upper right.

Pick another drug for a minute. Ask the same question about it.

Why is aspirin given for heart disease?

A cardiologist can walk you through the cascade in plain English. Damaged plaque inside an artery exposes tissue underneath. Platelets stick to the damaged spot. They release a signaling molecule called thromboxane A2, which makes more platelets stick. The growing clot can block the artery. Blood stops reaching the heart muscle. Heart attack.

Aspirin steps in early. It inhibits the COX-1 enzyme platelets use to make thromboxane A2. Less thromboxane. Less platelet stickiness. Fewer clots. Fewer heart attacks.

Five steps. A clean cascade. Each step has decades of evidence behind it. The mechanism is direct.

Now ask the same question about an SNRI.

The honest answer is: this drug blocks the transporters that recycle serotonin and norepinephrine in the synapse. More of those neurotransmitters stay active longer. Over four to six weeks, this may produce changes in receptors, circuits, and neuroplasticity that may reduce symptoms.

Read the FDA label for any SNRI and you'll find the word believed. The antidepressant mechanism in humans is believed to be associated with potentiating neurotransmitter activity in the central nervous system.

Believed.

Not measured in you. Not proven to be your specific problem. Believed.

That's a different kind of answer than aspirin. Aspirin tells you what is broken and how it is being fixed. An SNRI tells you a signal will be louder for longer, and maybe, over a month and a half, your symptoms will lift.

That may help some people. It does help some people.

But it's a symptom-modulation answer, not a disease-mechanism answer. And nobody told you that in the commercial.

· · ·

The variants nobody checks

Roughly half of Americans carry at least one MTHFR variant. Around half carry COMT V158M. Many men carry slow MAO-A on the X chromosome.

These aren't rare. These are common.

What they do: change how efficiently the kitchen runs. MTHFR variants slow the conversion of synthetic folic acid into the active methylfolate the brain actually uses. COMT and MAO-A variants slow the cleanup crew. People with them are already working with a kitchen that runs differently than the textbook average.

For some people, the system overloads. A biological illustration showing a stressed synapse: neurotransmitters being released in excess, the cleanup enzymes MAO-A and COMT and reuptake transporters all marked with warning triangles, signal chaos throughout the synaptic cleft.
From a foodZipper report
MTHFR C677T
+/+ · Reduced folate conversion
Spinach, lentils, liver, asparagus
Real folate · methylfolate forms
COMT V158M
+/- · Slow dopamine clearance
Pumpkin seeds, dark chocolate 70%+, cashews
Magnesium, B6, vitamin C
MAO-A R297R (hemizygous)
hemi · Slow neurotransmitter cleanup
Sardines, salmon, eggs, almonds
Riboflavin (B2), magnesium
A handful of variants. A handful of food matches. The kitchen runs differently for each person — but the cofactors come from the same shelves.

Now read that again with the 1998 fortification in mind.

The same year the FDA mandated synthetic folic acid into every enriched grain product, roughly half the population was carrying a variant that makes them process it less efficiently. Nobody asked who could process it and who couldn't. Nobody tested. Everyone got the same flour, the same bread, the same cereal, the same prenatal vitamin.

The unprocessed folic acid — the form your body couldn't convert — accumulates in blood. It shows up in 96% of breast milk samples. It's been detectable in children's serum since the mandate took effect. Nobody's running the long-term study on what that does to neurotransmitter production, methylation status, or psychiatric vulnerability.

Did anyone ask whether you could process synthetic folic acid before they put it in your bread?

Did anyone ask before they put it in your prenatal vitamin during pregnancy?

Published RCT data in the American Journal of Psychiatry (Papakostas et al., 2012): adding methylfolate — the form MTHFR carriers can actually use — to a standard antidepressant doubled the response rate. 14.6% on the drug alone. 32.3% on the drug plus methylfolate.

The methylfolate doubled the response rate.

That trial was significant enough that l-methylfolate is now sold by prescription as a medical food for depression. The data is published. If methylfolate can double response rates in SSRI-resistant depression, folate biology is not a side issue. It belongs in the first conversation.

Why isn't methylfolate the first thing anyone asks about?

· · ·

The test that costs less than the pills

You can find out if you carry these variants for sixty to a hundred dollars. AncestryDNA. 23andMe. The raw data file shows MTHFR, COMT, MAO-A, MTRR, VDR — all of it.

You can run that file through foodZipper for free.

The genetic test costs less than a single month of a brand-name antidepressant. Less than two co-pays. Less than the gas to drive to the pharmacy for the year.

It's not on the form. Nobody orders it. Nobody asks for it. The standard of care doesn't include it.

Why not?

The medical pharmacogenetics that does exist asks one question: can you metabolize this drug? The CYP2D6 and CYP2C19 panels. Those are useful — they tell you whether you'll process the pill normally or not.

But that's a question about the drug. Not about you.

foodZipper asks the other question. The one nobody else is asking. What was your biology doing before the drug entered the room? MTHFR. COMT. MAO-A. MTRR. VDR. The genes that make the signal and clear it in the first place.

Pharmacogenetics asks whether you can process the drug. foodZipper asks what your body was doing before anyone reached for the prescription pad.

· · ·

The version of the commercial you didn't see

The version of the commercial you didn't see. A woman sits across a wooden desk from a doctor in a wood-paneled office, holding a foodZipper Genetic Insights Summary report showing MTHFR, COMT, and MAO-A variants. The doctor listens with his hand to his chin. A wheat field is visible through the window. On the doctor's shelf: 'Nutritional Genomics' and 'Molecular Medicine.'

A woman walks into the doctor's office. Same wheat field outside the window. Same soft piano.

She doesn't ask about a drug.

She asks: Before we talk about a prescription, can we check my B12, my folate, my iron, my vitamin D, and my thyroid?

She asks: Here's my Ancestry report run through foodZipper. I carry slow variants in MTHFR and COMT. Am I a candidate for the drug you were about to prescribe?

She asks: If we do go with the drug, what's the exit plan?

The doctor pauses.

When's the last time anyone walked into the office asking those questions?

· · ·

Who's in charge

Before the questions, a frame.

Your doctor isn't in charge of you. You are.

This is not a hostile relationship. It's not adversarial. It's also not parental. Your doctor is a professional you hired to consult on something only you live in — your body. You bring the body. You bring the genetics. You bring the experience of being you. You bring the questions. They bring the training and the prescription pad.

You don't go to your accountant and accept just trust me on your tax return. You don't go to your mechanic and accept just trust me on a four-thousand-dollar repair. You ask questions. You expect answers in plain English. If the answers don't make sense, you get a second opinion.

It works the same way in medicine.

If your doctor gets annoyed when you ask questions — that's information. If they can't explain the basic mechanism of the drug they're prescribing — that's information. If they won't run the labs you're asking for — that's information. If they make you feel small for showing up with a foodZipper report and a list — that's information.

You're allowed to change doctors. You're allowed to want one who treats your biology like it's yours.

You're allowed to walk out. You're allowed to keep your records to yourself until you find a doctor who's a fit. You don't owe anyone your medical history just because they swiped your insurance card.

So walk in ready to ask.

· · ·

Ask your doctor

The commercial got one thing right. The two-word slogan was the most important thing it ever said.

So ask. About all of it. Don't accept trust me.

Make them explain the drug

Make them check my biochemistry first

Make them tell me the side effects honestly

Make them lay out the exit

Make them justify why this and not something else

Make them answer the bigger picture

If your doctor can answer all of these — great. You're in good hands. If they can't, or won't, or get annoyed at the questions — that's information too.

You're not being difficult. You're being a patient. If your doctor can't make space for these questions, find one who can.

· · ·

What to do

Feed the system your DNA was built for. Real food on the left — kale, spinach, lentils, eggs, beef liver, salmon — flowing through golden DNA into a healthy neuron showing complete neurotransmitter synthesis, release, and clearance.

Run the test. Bring the report. Ask the questions.

Real folate from spinach, lentils, liver, asparagus. Real B12 from animal protein. Riboflavin from eggs, dairy, almonds. Magnesium from greens and pumpkin seeds. The cofactors your methylation cycle actually needs, in the forms your body can actually use.

Food sets the floor. Exercise opens the valve. Medication changes the signal. All three are tools. The order matters.

Before we slow reuptake, before we inhibit cleanup, before we raise the dose — did anyone check the pantry?

Change the way you eat. Change the way you feel. That's foodZipper. A glowing golden DNA helix above the foodZipper wordmark, with spinach, lentils, eggs, salmon, blueberries, walnuts, and almonds arranged at the bottom.

Change the way you eat. Change the way you feel. That's foodZipper.

— B+

· · ·

Published research cited in this post

L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials — Papakostas GI et al., American Journal of Psychiatry, 2012

Antidepressant use among persons aged 12 and over: United States, 2011–2014 — Pratt LA, Brody DJ, Gu Q., NCHS Data Brief No. 283, 2017

Antidepressant use among adults: United States, 2015–2018 — Brody DJ, Gu Q., NCHS Data Brief No. 377, 2020

Total folate and unmetabolized folic acid in the breast milk of a cross-section of Canadian women — Page R et al., American Journal of Clinical Nutrition, 2017

The serotonin theory of depression: a systematic umbrella review of the evidence — Moncrieff J et al., Molecular Psychiatry, 2022

A systematic review into the incidence, severity and duration of antidepressant withdrawal effects — Davies J, Read J., Addictive Behaviors, 2019

Royal College of Psychiatrists position statement on antidepressants and depression, 2019

foodZipper is free. Your file never leaves your device. Upload your DNA and see your report.